TOP1 and cancer: An interesting target for cancer treatment is TDP1, which plays a key role in the removal of DNA damage produced by TOP1 inhibition by clinically important anticancer drugs (irinotecan, Tpc) as well as removal of DNA damage caused by other anticancer drugs.